RONOMA PROJECT
Drug Candidate Neocoprid
The company RonomA, a biotechnology company born from research in Normandy, aims to bring to market an innovative treatment for neurodegenerative diseases
- Activation of serotonergic receptors
- Acetylcholinesterase inhibition
Our Specialties
Explore Our Main Services
Our excellent teaam is ready to be part of your team to work into the different areas
WHO ARE WE
Our Team
Coopération impliquant Romain Legrand, qui est à la fois le fondateur et le directeur de l'entreprise, ainsi que Patrick Dallemagne et Christophe Rochais. Ces derniers, co-fondateurs et distingués enseignants-chercheurs en chimie médicale, sont affiliés au Centre d'Études et de Recherche sur le Médicament de Normandie (CERMN) à l'Université de Caen Normandie.
SCIENTIFIC PUBLICATIONS
Our Latest Publications
Find out about our latest publications and the progress of Ronoma’s studies
Blog
Recent Posts
Various news concerning Alzheimer and Ronoma. Videos and articles.
Testimonials
Our Latest Case Studies
Our collaboration projects between the public sector, industry and academia bring a real impact for the our health and lab firms.